BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29247171)

  • 1. Computer-Aided Nodule Assessment and Risk Yield (CANARY) may facilitate non-invasive prediction of EGFR mutation status in lung adenocarcinomas.
    Clay R; Kipp BR; Jenkins S; Karwoski RA; Maldonado F; Rajagopalan S; Voss JS; Bartholmai BJ; Aubry MC; Peikert T
    Sci Rep; 2017 Dec; 7(1):17620. PubMed ID: 29247171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations.
    Li M; Zhang L; Tang W; Duan JC; Jin YJ; Qi LL; Wu N
    Cancer Imaging; 2019 Nov; 19(1):77. PubMed ID: 31783917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive characterization of the histopathologic features of pulmonary nodules of the lung adenocarcinoma spectrum using computer-aided nodule assessment and risk yield (CANARY)--a pilot study.
    Maldonado F; Boland JM; Raghunath S; Aubry MC; Bartholmai BJ; Deandrade M; Hartman TE; Karwoski RA; Rajagopalan S; Sykes AM; Yang P; Yi ES; Robb RA; Peikert T
    J Thorac Oncol; 2013 Apr; 8(4):452-60. PubMed ID: 23486265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth.
    Kobayashi Y; Mitsudomi T; Sakao Y; Yatabe Y
    Ann Oncol; 2015 Jan; 26(1):156-161. PubMed ID: 25361983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
    Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
    Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of CT radiogenomic and clinical characteristics between EGFR and KRAS mutations in lung adenocarcinomas.
    Lv J; Zhang H; Ma J; Ma Y; Gao G; Song Z; Yang Y
    Clin Radiol; 2018 Jun; 73(6):590.e1-590.e8. PubMed ID: 29454587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations.
    Ruiz-Cordero R; Ma J; Khanna A; Lyons G; Rinsurongkawong W; Bassett R; Guo M; Routbort MJ; Zhang J; Skoulidis F; Heymach J; Roarty EB; Tang Z; Medeiros LJ; Patel KP; Luthra R; Roy-Chowdhuri S
    BMC Cancer; 2020 Jan; 20(1):83. PubMed ID: 32005111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the inter-observer variability of Computer-Aided Nodule Assessment and Risk Yield (CANARY) to characterize lung adenocarcinomas.
    Nakajima EC; Frankland MP; Johnson TF; Antic SL; Chen H; Chen SC; Karwoski RA; Walker R; Landman BA; Clay RD; Bartholmai BJ; Rajagopalan S; Peikert T; Massion PP; Maldonado F
    PLoS One; 2018; 13(6):e0198118. PubMed ID: 29856852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational profile of Brazilian lung adenocarcinoma unveils association of EGFR mutations with high Asian ancestry and independent prognostic role of KRAS mutations.
    Leal LF; de Paula FE; De Marchi P; de Souza Viana L; Pinto GDJ; Carlos CD; Berardinelli GN; Miziara JE; da Silva CM; Silva ECA; Pereira R; de Oliveira MA; Scapulatempo-Neto C; Reis RM
    Sci Rep; 2019 Mar; 9(1):3209. PubMed ID: 30824880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma.
    Takamochi K; Mogushi K; Kawaji H; Imashimizu K; Fukui M; Oh S; Itoh M; Hayashizaki Y; Ko W; Akeboshi M; Suzuki K
    PLoS One; 2017; 12(4):e0175622. PubMed ID: 28422979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of EGFR mutations by conventional CT-features in advanced pulmonary adenocarcinoma.
    Chen Y; Yang Y; Ma L; Zhu H; Feng T; Jiang S; Wei Y; Wang T; Sun X
    Eur J Radiol; 2019 Mar; 112():44-51. PubMed ID: 30777218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic features of surgically resected pathological stage I lung adenocarcinoma harboring epidermal growth factor receptor and K-ras mutation.
    Kaseda K; Asakura K; Kazama A; Ozawa Y
    Thorac Cancer; 2017 May; 8(3):229-237. PubMed ID: 28322512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
    Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
    Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection and Analysis of EGFR and KRAS Mutation with Lung Adenocarcinoma].
    Zhang H; Yang X; Qin N; Li X; Yang H; Nong J; Lv J; Wu Y; Zhang Q; Zhang X; Wang J; Zhou L; Zhang S
    Zhongguo Fei Ai Za Zhi; 2015 Nov; 18(11):686-90. PubMed ID: 26582224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial.
    Maldonado F; Duan F; Raghunath SM; Rajagopalan S; Karwoski RA; Garg K; Greco E; Nath H; Robb RA; Bartholmai BJ; Peikert T
    Am J Respir Crit Care Med; 2015 Sep; 192(6):737-44. PubMed ID: 26052977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma.
    Clay TD; Russell PA; Do H; Sundararajan V; Conron M; Wright GM; Solomon B; Dobrovic A; McLachlan SA; Moore MM
    Med Oncol; 2017 Sep; 34(10):175. PubMed ID: 28879441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Software-based risk stratification of pulmonary adenocarcinomas manifesting as pure ground glass nodules on computed tomography.
    Nemec U; Heidinger BH; Anderson KR; Westmore MS; VanderLaan PA; Bankier AA
    Eur Radiol; 2018 Jan; 28(1):235-242. PubMed ID: 28710575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas.
    Guerrera F; Renaud S; Tabbó F; Voegeli' AC; Filosso PL; Legrain M; Boita M; Schaeffer M; Beau-Faller M; Ruffini E; Falcoz PE; Inghirami G; Oliaro A; Massard G
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):680-688. PubMed ID: 28329143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer Aided Nodule Analysis and Risk Yield (CANARY) characterization of adenocarcinoma: radiologic biopsy, risk stratification and future directions.
    Clay R; Rajagopalan S; Karwoski R; Maldonado F; Peikert T; Bartholmai B
    Transl Lung Cancer Res; 2018 Jun; 7(3):313-326. PubMed ID: 30050769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.